CINA CHEST vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

CINA CHEST is an AI-powered radiological triage tool for the rapid detection of acute conditions like Pulmonary Embolism and Aortic Dissection from CT scans. In contrast, SensiCardiac Mobi is a mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. While both leverage AI for cardiac assessment, their distinct input modalities (imaging vs. acoustics) and specific clinical applications mean they address different diagnostic challenges and workflows.

Choose CINA CHEST if…

Choose CINA CHEST if your emergency department or radiology practice requires rapid, AI-powered triage and notification for life-threatening conditions like Pulmonary Embolism and Aortic Dissection on CT angiography scans. This tool is ideal for streamlining workflow and prioritizing critical cases to reduce time to treatment in high-volume settings.

View CINA CHEST →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you are a physician in a clinical setting (e.g., primary care, cardiology, pediatrics) needing AI-assisted analysis of heart sounds from an electronic stethoscope. This mobile application is best suited for aiding in the differentiation between physiological and pathological heart murmurs, supporting clinical decision-making and guiding further diagnostic steps.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Subscription-based	Contact for pricing
Deployment	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	K210237 AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CINA CHEST

CINA CHEST (Tool A) offers superior usability due to its flexible deployment options (cloud, on-premise, virtualized) and seamless integration into existing radiology workflows as a standalone web application that provides notifications. SensiCardiac Mobi (Tool B), while mobile, requires specific hardware (iPhone, compatible electronic stethoscope) and a hosted server environment, which can introduce more complexity for users and IT integration.

Clinical Value

CINA CHEST

CINA CHEST (Tool A) provides rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism and Aortic Dissection on CT scans, directly impacting emergency workflow and patient outcomes by accelerating critical decision-making. SensiCardiac Mobi (Tool B) assists in diagnosing heart murmurs, which is valuable but addresses conditions that are generally less acute and time-sensitive than those targeted by CINA CHEST.

Pricing & Value

Tie

Both tools maintain opaque pricing models, with details available only upon request or by contacting the company. Without specific pricing information for either CINA CHEST or SensiCardiac Mobi, it is impossible to conduct a meaningful head-to-head comparison of their value propositions.

Enterprise Readiness

CINA CHEST

CINA CHEST (Tool A) demonstrates stronger enterprise readiness with its diverse deployment options (cloud, on-premise, virtualized) and proven track record of deployment in over 140 hospitals across 14 countries. Its design to assist 'hospital networks' and seamless integration into existing radiology workflows further supports its enterprise suitability. SensiCardiac Mobi (Tool B)'s reliance on a specific mobile device and a hosted server environment may present more limitations for large-scale enterprise adoption.

Innovation

Tie

Both tools showcase significant innovation in their respective fields by leveraging AI. CINA CHEST (Tool A) innovates by applying deep learning for rapid, critical triage in radiology, optimizing emergency workflows. SensiCardiac Mobi (Tool B) innovates by bringing AI-powered analysis of heart sounds to the point of care via a mobile application, enhancing a traditionally subjective examination.

Support & Docs

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

While detailed information on support channels is lacking for both, SensiCardiac Mobi (Tool B) explicitly mentions 'instructions for use' as part of its system and references to a 'SensiCardiac Diagnostic Heart Murmur Software Manual' and 'SensiCardiac General Warnings' were found. For CINA CHEST (Tool A), no specific documentation or support channels were identified in the provided information or search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Name	CINA CHEST	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Avicenna.AI	DIACOUSTIC MEDICAL DEVICES (PTY)
Primary Function	AI-powered radiological triage and notification software for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.	AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope.
Target Conditions	Pulmonary Embolism (PE) and Aortic Dissection (AD)	Physiological and pathological heart murmurs
Input Data Type	CT angiography scans	Acoustic heart signals from an electronic stethoscope

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply do these tools integrate with existing hospital information systems, such as PACS/RIS for CINA CHEST and EHRs for SensiCardiac Mobi, to streamline documentation and result communication?

CINA CHEST is designed for seamless integration into existing radiology workflows, directly integrating with PACS and RIS without requiring new viewers or changes to current workflows. It operates automatically in the background, flagging suspected findings and providing notifications with compressed preview images for informational purposes. SensiCardiac Mobi, as a mobile application, captures and displays heart sound data, and its reports are presented as downloadable PDFs, which can then be integrated into EHRs.

Can you provide more detailed clinical performance metrics, such as sensitivity, specificity, and positive/negative predictive values, from clinical studies for each tool?

For CINA CHEST, studies have shown varying performance metrics depending on the condition. For Aortic Dissection (AD), it demonstrated a sensitivity of 94.2% and a specificity of 97.3%. For Pulmonary Embolism (PE), CINA CHEST has shown a sensitivity of 91.1% and a specificity of 91.8%. SensiCardiac Mobi's underlying algorithm has reported an accuracy above 95% for murmur detection, with a specificity of 94% and sensitivity of 84% relative to a 'golden standard' echo.

Beyond the listed specialties, in which specific clinical scenarios or patient populations has each tool demonstrated the most significant impact or utility?

CINA CHEST is particularly impactful in emergency radiology settings for rapid triage of life-threatening PE and AD, where timely detection is critical for patient outcomes. It also has utility in detecting incidental pulmonary embolisms on routine CT scans performed for other conditions, especially in cancer patients, which can prevent missed diagnoses and enable early treatment. SensiCardiac Mobi is highly beneficial in primary care and pediatric settings for assisting physicians in differentiating between physiological and pathological heart murmurs, potentially reducing unnecessary referrals to specialists.

What is the expected learning curve for physicians and their clinical teams to become proficient in using each tool, and what training resources are provided?

CINA CHEST is designed to be 'invisible' to end-users, integrating into existing workflows without requiring extra training or changes to how radiologists operate. SensiCardiac Mobi, while a mobile application, guides users through the auscultation process graphically and provides real-time analysis, with usability validation showing high user satisfaction. Training resources would typically include instructions for use and potentially in-app guidance for SensiCardiac Mobi, while CINA CHEST emphasizes minimal disruption and no additional training.

What level of auditability and traceability do these tools offer for AI-generated findings and subsequent physician decisions?

Avicenna.AI's platform, which includes CINA CHEST, provides comprehensive audit logging and auditable operations to guarantee patient privacy and track AI-generated findings. This allows for traceability of the AI's analysis and how it interacts with the clinical workflow. For SensiCardiac Mobi, the system acquires and records acoustic heart signals and provides detailed cardiac reports as downloadable PDFs, which can serve as an audit trail for the heart sound analysis and physician's assessment.

For healthcare systems considering a multi-site rollout, what are the key considerations and support mechanisms available for deploying each tool across different facilities?

Avicenna.AI's AVI platform, which hosts CINA CHEST, is designed for scalability from single sites to large networks, offering centralized configuration and orchestration capabilities for managing AI applications from a single interface. It integrates seamlessly into existing healthcare systems via global standards like DICOM, HL7, and FHIR. For SensiCardiac Mobi, the platform is described as having scalable business models to support growth, with multiple facilities able to be centralized on its user management system with integrated billing.